Ignite Creation Date:
2024-05-06 @ 3:08 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02219971
Status:
COMPLETED
Last Update Posted:
2017-05-03
First Post:
2014-08-16
Brief Title:
Phase I Study of Kukoamine B Mesilate in Healthy Volunteers
Sponsor:
Tianjin Chasesun Pharmaceutical Co LTD
Organization:
Tianjin Chasesun Pharmaceutical Co LTD
Study Overview
Official Title:
Randomized Double-blind Placebo-controlled Phase I Study to Assess Safety Tolerance and Pharmacokinetics of a Single Intravenous Injection Kukoamine B Mesilate in Healthy Volunteers
Status:
COMPLETED
Status Verified Date:
2016-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess safety tolerance and pharmacokinetics of a single intravenous injection Kukoamine B Mesilate in health volunteer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ChiCTR-TRC-14005111 | REGISTRY | Chinese Clinical Trial Registry | None |